Published in Medical Patent Business Week, December 22nd, 2006
1) Positive developments continued with AspenBio Pharma's unique blood-based human appendicitis test. Results from initial clinical testing conducted at multiple hospitals continued during the quarter and show the test achieving definitive indications of a high level of correlation with acute appendicitis in the age group most likely to experience the condition, and thereby suggesting tremendous diagnostic value. The company believes its test would represent significant advantages in the state of the art techniques as currently used by emergency room doctors to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.